BioRestorative Therapies Inc BRTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/30/22 EDT
2.95quote price arrow down-0.49 (-14.24%)
Volume
64,857
52 week range
2.75 - 32.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.95
  • 52 Week High32.00
  • 52 Week High Date07/09/21
  • 52 Week Low2.75
  • 52 Week Low Date06/30/22

Key Stats

  • Market Cap10.74M
  • Shares Out3.64M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta7.60
  • YTD % Change-32.03

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.95
  • 52 Week High32.00
  • 52 Week High Date07/09/21
  • 52 Week Low2.75
  • 52 Week Low Date06/30/22
  • Market Cap10.74M
  • Shares Out3.64M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta7.60
  • YTD % Change-32.03

RATIOS/PROFITABILITY

  • EPS (TTM)-20.03
  • P/E (TTM)-0.15
  • Fwd P/E (NTM)-1.94
  • EBITDA (TTM)-16.216M
  • ROE (TTM)-383.63%
  • Revenue (TTM)40,000.00
  • Gross Margin (TTM)31.67%
  • Net Margin (TTM)-76,059.37%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioRestorative Therapies Inc

There is no recent news for this security.

Profile

MORE
BioRestorative Therapies, Inc. is a life sciences company, which is focused on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. It offers two developmental programs, namely Disc/Spine Program (brtxDisc) and Metabolic Program (ThermoStem), which relate to the treatment of disc/spinedisease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product...
Address
40 Marcus Dr
Melville, NY
11747-4269
United States